4//SEC Filing
Pedulla Denise E 4
Accession 0001077183-20-000039
CIK 0001077183other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:16 PM ET
Size
12.5 KB
Accession
0001077183-20-000039
Insider Transaction Report
Form 4
Pedulla Denise E
General Counsel
Transactions
- Award
Common Stock
2020-03-02+2,912→ 43,988 total - Award
Common Stock
2020-03-02$28.33/sh+18,757$531,386→ 18,757 totalExercise: $28.33From: 2021-03-02Exp: 2027-03-02→ Common Stock (18,757 underlying)
Holdings
- 15,000
Common Stock
Exercise: $7.85From: 2016-12-08Exp: 2020-12-08→ Common Stock (15,000 underlying) - 48,334
Common Stock
Exercise: $8.03From: 2019-02-26Exp: 2023-02-26→ Common Stock (48,334 underlying) - 17,496
Common Stock
Exercise: $19.60From: 2020-03-01Exp: 2024-03-01→ Common Stock (17,496 underlying) - 25,000
Common Stock
Exercise: $7.52From: 2018-04-28Exp: 2022-04-28→ Common Stock (25,000 underlying)
Footnotes (5)
- [F1]On December 8, 2015, Ms. Pedulla was granted 60,000 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F2]On April 28, 2017, Ms. Pedulla was granted 75,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F3]On January 26, 2018, Ms. Pedulla was granted 72,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F4]On March 1, 2019, Ms. Pedulla was granted 17,496 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F5]On March 2, 2020, Ms. Pedulla was granted 18,757 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001804602
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 8:16 PM ET
- Size
- 12.5 KB